Vous n'êtes pas identifié (connexion)

Centre de recherche

BOTTIN

Fernand Labrie

Formation
à venir

Aucune offre active

Autres opportunités de carrière
Axe principal
Endocrinologie et néphrologie
Adresse(s)
Centre Hospitalier de l'Université Laval (CHUL)
2705, boulevard Laurier
R-4720
Québec (Québec)
CANADA G1V 4G2

Téléphone(s)
+1 418-525-4444, poste 42296
Télécopieur(s)
Courriel(s)
fernand.labrie@crchudequebec.ulaval.ca

Projet(s) de recherche reconnu(s) par l'Université Laval

Autre(s) projet(s) de recherche actif(s)

Aucun projet de recherche à afficher

Publications récentes (voir toutes les publications de ce chercheur)

Zethraeus N, Dreber A, Ranehill E, Blomberg L, Labrie F, von Schoultz B, Johannesson M, Hirschberg AL. A first-choice combined oral contraceptive influences general well-being in healthy women: a double-blind, randomized, placebo-controlled trial. Fertility and sterility,  2017. 107: 1238-1245
Labrie F, Martel C. A low dose (6.5 mg) of intravaginal DHEA permits a strictly local action while maintaining all serum estrogens or androgens as well as their metabolites within normal values. Hormone Molecular Biology and Clinical Investigation,  2017. 29: 39-60
Labrie F, Martel C, Belanger A, Pelletier G. Androgens in women are essentially made from DHEA in each peripheral tissue according to intracrinology. The Journal of steroid biochemistry and molecular biology,  2017. 168: 9-18
Archer DF, Labrie F, Montesino M, Martel C. Comparison of intravaginal 0.5% prasterone, 0.3mg conjugated estrogens and 10mug estradiol on estrogen-related symptoms of vulvovaginal atrophy. The Journal of steroid biochemistry and molecular biology,  2017. Epub
Ke Y, Gonthier R, Labrie F. Impact of sample extraction on the accurate measurement of progesterone in human serum by liquid chromatography tandem mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences ,  2017. 1052: 110-120
Labrie F, Belanger A, Pelletier G, Martel C, Archer DF, Utian WH. Science of intracrinology in postmenopausal women. Menopause (New York, N.Y.) ,  2017. Epub
Martel C, Labrie F, Archer DF, Ke Y, Gonthier R, Simard JN, Lavoie L, Vaillancourt M, Montesino M, Balser J, Moyneur E, other participating members of the Prasterone Clinical Research Group. Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12 weeks. The Journal of steroid biochemistry and molecular biology,  2016. Epub
Bouchard C, Labrie F, Derogatis L, Girard G, Ayotte N, Gallagher J, Cusan L, Archer DF, Portman D, Lavoie L, Beauregard A, Cote I, Martel C, Vaillancourt M, Balser J, Moyneur E, other participating Members of the VVA Prasterone Group. Effect of intravaginal dehydroepiandrosterone (DHEA) on the female sexual function in postmenopausal women: ERC-230 open-label study. Hormone Molecular Biology and Clinical Investigation,  2016. 25: 181-90
Dury AY, Ke Y, Labrie F. Precise and accurate assay of pregnenolone and five other neurosteroids in monkey brain tissue by LC-MS/MS. Steroids,  2016. Epub
Ke Y, Gonthier R, Labrie F. The conversion of 16beta hydroxyldehydroepiandrosterone in human serum. Steroids,  2016. 109: 50-5
© 2017 Tous droits réservés Centre de recherche du CHU de Québec